Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02641002
Title A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Phoenix Arizona 85054 United States Details
UCLA Division of Hematology Oncology Los Angeles California 90095-1752 United States Details
Yale Cancer Center New Haven Connecticut 06510 United States Details
University of Chicago Chicago Illinois 60637 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field